JP2016155880A5 - - Google Patents

Download PDF

Info

Publication number
JP2016155880A5
JP2016155880A5 JP2016116373A JP2016116373A JP2016155880A5 JP 2016155880 A5 JP2016155880 A5 JP 2016155880A5 JP 2016116373 A JP2016116373 A JP 2016116373A JP 2016116373 A JP2016116373 A JP 2016116373A JP 2016155880 A5 JP2016155880 A5 JP 2016155880A5
Authority
JP
Japan
Prior art keywords
use according
delivery vehicle
medicament
ethanol
vasoconstrictor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016116373A
Other languages
English (en)
Japanese (ja)
Other versions
JP6473103B2 (ja
JP2016155880A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016155880A publication Critical patent/JP2016155880A/ja
Publication of JP2016155880A5 publication Critical patent/JP2016155880A5/ja
Application granted granted Critical
Publication of JP6473103B2 publication Critical patent/JP6473103B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016116373A 2005-06-17 2016-06-10 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法 Active JP6473103B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69157105P 2005-06-17 2005-06-17
US60/691,571 2005-06-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015039086A Division JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018190933A Division JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Publications (3)

Publication Number Publication Date
JP2016155880A JP2016155880A (ja) 2016-09-01
JP2016155880A5 true JP2016155880A5 (OSRAM) 2017-07-06
JP6473103B2 JP6473103B2 (ja) 2019-02-20

Family

ID=37570784

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2008517201A Active JP5756250B2 (ja) 2005-06-17 2006-06-19 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2015039086A Active JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2016116373A Active JP6473103B2 (ja) 2005-06-17 2016-06-10 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2018190933A Withdrawn JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008517201A Active JP5756250B2 (ja) 2005-06-17 2006-06-19 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法
JP2015039086A Active JP6348437B2 (ja) 2005-06-17 2015-02-27 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018190933A Withdrawn JP2018203788A (ja) 2005-06-17 2018-10-09 癌の化学療法および放射線療法の際に細胞を保護するための局所的血管収縮剤および方法

Country Status (15)

Country Link
US (4) US8114914B2 (OSRAM)
EP (2) EP1890732B1 (OSRAM)
JP (4) JP5756250B2 (OSRAM)
CN (3) CN101198362B (OSRAM)
AU (1) AU2006261358B2 (OSRAM)
CA (1) CA2611496C (OSRAM)
DK (2) DK2656860T3 (OSRAM)
ES (2) ES2675228T3 (OSRAM)
HK (1) HK1245143A1 (OSRAM)
HU (2) HUE038177T2 (OSRAM)
IL (2) IL191869A (OSRAM)
PL (2) PL1890732T3 (OSRAM)
PT (2) PT2656860T (OSRAM)
TR (1) TR201809015T4 (OSRAM)
WO (1) WO2006138691A1 (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
CN101010305B (zh) 2004-08-20 2010-08-11 曼金德公司 二酮哌嗪合成的催化反应
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
EP1890732B1 (en) * 2005-06-17 2018-03-28 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
KR101384456B1 (ko) 2005-09-14 2014-04-10 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
ES2647080T3 (es) 2006-02-22 2017-12-19 Mannkind Corporation Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
US8785396B2 (en) * 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
EP2165706A1 (en) * 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
ES2625858T3 (es) 2011-04-01 2017-07-20 Mannkind Corporation Paquete de tipo blíster para cartuchos farmacéuticos
JP2014515400A (ja) * 2011-06-02 2014-06-30 プロサータス バイオファーム、インコーポレイテッド 有機溶媒中に形成された式量の小さいアドレナリン作動薬塩の製剤
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
CA3098386C (en) 2012-07-12 2022-11-29 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
MX369136B (es) 2013-03-15 2019-10-30 Mannkind Corp Composiciones de dicetopiperazina microcristalina y metodos.
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CA2967375C (en) * 2014-11-14 2023-08-15 Follea International System and method for preventing alopecia
EP3307280B1 (en) 2015-06-11 2021-10-27 Rejoy Treatment of sexual dysfunction
EP3651767A1 (en) 2017-07-14 2020-05-20 Galderma Research & Development Methods and compositions for reducing side effects in chemotherapeutic treatments
WO2019032573A1 (en) * 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
WO2020113028A1 (en) * 2018-11-27 2020-06-04 The Trustees Of Columbia University In The City Of New York Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
BR112022000875A2 (pt) 2019-07-19 2022-03-29 Finch Therapeutics Holdings Llc Métodos e produtos para tratamento de distúrbios gastrointestinais
WO2021084541A1 (en) * 2019-10-31 2021-05-06 Sol-Gel Technologies Ltd. Treatment of hair loss disorders with a topical egfr inhibitor
WO2023130086A1 (en) * 2021-12-31 2023-07-06 Jss Research, Llc Compositions and methods for topical treatment of vascular conditions
KR20240154540A (ko) 2022-03-04 2024-10-25 바소다이나믹스 리미티드 국소 조성물 및 방법
CN119313747B (zh) * 2024-12-17 2025-04-15 中国海洋大学三亚海洋研究院 一种鱼类表皮体色量化方法和装置

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2414918A (en) * 1941-09-23 1947-01-28 Abramson Harold Alexander Solutions for the improved nebulization therapy of the lungs and bronchioles
US2774789A (en) * 1947-10-24 1956-12-18 Sterling Drug Inc 1-arterenol and its acid-addition salts and preparation thereof
US2919230A (en) * 1953-10-29 1959-12-29 Rohm & Haas Hydrophilic base therapeutic compositions comprising cation-exchange resin
BE555319A (OSRAM) * 1956-03-21 1900-01-01
US3039922A (en) * 1959-08-17 1962-06-19 Carter Prod Inc Method of administering tablets having decongestant and anti-histaminic activity
US3134720A (en) * 1962-06-27 1964-05-26 Bristol Myers Co Medicated gels
US3574859A (en) * 1968-07-05 1971-04-13 Carl M Kosti Process for the treatment of hypertrophied gums
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
US4853216A (en) * 1987-04-02 1989-08-01 Bristol-Myers Company Process and composition for the topical application of alpha1 adrenergic agonist for pilomotor effects
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5013716A (en) 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
US5374645A (en) * 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
JPH04327533A (ja) 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
US5534242A (en) 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
NL9401183A (nl) 1994-07-19 1996-03-01 Nederland Ptt Modulator/demodulatorinrichting voor koppeling van een dataterminal met een zend/ontvanginrichting, alsmede werkwijzen voor het tot stand brengen van een dataverbinding tussen een eerste en een tweede modulator/demodulatorinrichting.
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
CA2154979A1 (en) 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6635678B1 (en) 1996-12-23 2003-10-21 S.L.A. Pharma Ag Pharmaceutical composition for treating fecal incontinence
GB2370989A (en) 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
JP2001131085A (ja) * 1999-08-25 2001-05-15 Saitama Daiichi Seiyaku Kk 経皮・経粘膜吸収用の医薬組成物
CA2401288A1 (en) * 2000-02-28 2001-09-07 Vectura Limited Improvements in or relating to the delivery of oral drugs
US6375982B1 (en) 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
CA2424770A1 (en) 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
EP1363602A4 (en) 2001-01-25 2006-01-11 Euro Celtique Sa LOCAL ANESTHESIA, AND METHOD OF USE
WO2002064113A1 (en) 2001-02-15 2002-08-22 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20020192273A1 (en) 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP4544391B2 (ja) * 2001-12-28 2010-09-15 ライオン株式会社 眼科用組成物
US6919348B2 (en) * 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US7314959B2 (en) * 2003-08-07 2008-01-01 Wisconsin Alumni Research Foundation Amino thiol compounds and compositions for use in conjunction with cancer therapy
EP1656102A2 (en) 2003-08-21 2006-05-17 Transoral Pharmaceuticals, Inc. Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
US20070219253A1 (en) * 2003-09-17 2007-09-20 Gul Balwani Decongestant / antihistaminic / expectorant compositions
EP1737434A2 (en) 2004-04-13 2007-01-03 Alza Corporation Apparatus and method for transdermal delivery of fentanyl-based agents
EP1890732B1 (en) * 2005-06-17 2018-03-28 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy

Similar Documents

Publication Publication Date Title
JP2016155880A5 (OSRAM)
MX2024010140A (es) Nuevos metodos.
MX2021000376A (es) Composiciones tópicas para el alivio del dolor.
JP2017149726A5 (OSRAM)
AR090349A1 (es) Terapia de combinacion para trastornos proliferativos, kit y uso
NZ749192A (en) Ar+ breast cancer treatment methods
MX2021002322A (es) Nuevos metodos.
EA202190115A1 (ru) Пленочные составы, содержащие дексмедетомидин, и способы их получения
DOP2018000196A (es) Metodos para tratar la depresion con antagonistas del receptor de orexina-2
NZ714963A (en) Compositions and methods for treating anemia
PH12015502628A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
RU2016105581A (ru) Способ лечения острого, хронического и подострого кашля и непреодолимого желания откашляться
JP2014516942A5 (OSRAM)
AR074471A1 (es) Compuesto 5(5-(2-(3-aminopropoxi) - 6 - metoxifenil) -1h- pirazol-3- ilamino ) pirazin -2-carbonitrilo , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para inhibir chk1 y para tratar cancer
EA202090637A1 (ru) Способы применения дипивефрина
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
CO6280574A2 (es) Metodos para utilizar antagonistas de vasopresina con agentes de quimioterapia con antraciclina para reducir la cardiotoxicidad y/o para mejorar la supervivencia
CO6771406A2 (es) Una composición combinada
HRP20220375T1 (hr) Kombinirana terapija inhibitorom bromodomenskog i ekstraterminalnog proteina
MX2019001850A (es) Formulaciones para administracion oral de principios activos.
CR20160037A (es) Formas de dosificación farmacéuticas estabilizadas que comprenden atrasentán
CL2022003039A1 (es) Inhibidores de il4i1 y métodos de uso.
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
AR074793A1 (es) Composiciones farmaceuticas liquidas que comprenden triptan y xilitol para tratar la migrana